Significant association of serum albumin with severity of retinopathy and neuropathy, in addition to that of nephropathy, in Japanese type 2 diabetic patients

Endocrine Journal

Volumn 55, Issue 2, 2008, Pages 311-316

  Iwasaki, Tomoyuki ^a   Togashi, Yu ^a   Terauchi, Yasuo ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Albumin; Microvascular complication; Nephropathy; Neuropathy; Retinopathy

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN;

ACHILLES REFLEX; ADULT; ALBUMIN BLOOD LEVEL; ANALYTIC METHOD; AREFLEXIA; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC RETINOPATHY; DISEASE SEVERITY; FEMALE; HUMAN; KIDNEY DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MOTOR NERVE CONDUCTION; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA;

AGED; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; HYPOALBUMINEMIA; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; PROTEINURIA; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX;

EID: 43449089541     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K07-086     Document Type: Article

References (11)

1. Leehey DJ, Kramer HJ, Daoud TM, Chatha MP, Isreb MA (2005) Progression of kidney disease in type 2 diabetes - beyond blood pressure control: an observational study. BMC Nephrol 6: 8.
2. Davis MD, Myers FL, Bresnick GH, Venecia G (1977) Natural evolution. In: Current Diagnosis and Management of Chorioretinal Diseases. L'Esperance FA Jr, Ed. St. Louis, MO, CV. Mosby: 179-184.
3. Kohara N, Kimura J, Kaji R, Goto Y, Ishii J, Takiguchi M, Nakai M (2000) F-wave latency serves as the most reproducible measure in nerve conduction studies of diabetic polyneuropathy: multicentre analysis in healthy subjects and patients with diabetic polyneuropathy. Diabetologia 43: 915-921.
4. Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving H-H (2004) Progression of nephropathy in type 2 diabetic patients. Kidney Int. 66: 1596-1605.
5. Folsom AR, Ma J, Eckfeldt JH, Nieto FJ, Metcalf PA, Barnes RW (1995) Low serum albumin. Association with diabetes mellitus and other cardiovascular risk factors but not with prevalent cardiovascular disease or carotid artery intima-media thickness. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Ann Epidemiol 5: 186-191.
6. Moshage HJ, Janssen JA, Franssen JH, Hafkenscheid JC, Yap SH (1987) Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation. J Clin Invest 79: 1635-1641.
7. Festa A, D'Agostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102: 42-47.
8. Iwasaki T, Nakajima A, Yoneda M, Terauchi Y (2006) Relationship between the serum concentrations of C-reactive protein and parameters of adiposity and insulin resistance in patients with type 2 diabetes mellitus. Endocr J 53: 345-356.
9. Yokoyama H, Tomonaga O, Hirayama M, Ishii A, Takeda M, Babazono T, Ujihara U, Takahashi C, Omori Y (1997) Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients. Diabetologia 40: 405-411.
10. Earle KA, Mishra M, Morocutti A, Barnes D, Stephens E, Chambers J, Viberti GC (1996) Microalbuminuria as a marker of silent myocardial ischaemia in IDDM patients. Diabetologia 39: 854-856.
11. Wachtell K, Dahlof B, Rokkedal J, Papademetriou V, Nieminen MS, Smith G, Gerdts E, Boman K, Bella JN, Devereux RB (2002) Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. Am Heart J 144: 1057-1064.